Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

Persistent high-risk HPV infection is closely associated with cervical cancer development, and there is no drug targeting HPV on the market at present, so it is particularly important to understand the interaction mechanism between HPV and the host which may provide the novel strategies for treating HPV diseases. HPV can hijack cell surface heparan sulfate proteoglycans (HSPGs) as primary receptors. However, the secondary entry receptors for HPV remain elusive. We identify myosin-9 (NMHC-IIA) as a host factor that interacts with HPV L1 protein and mediates HPV internalization. Efficient HPV entry required myosin-9 redistribution to the cell surface regulated by HPV-hijacked MEK-MLCK signaling. Myosin-9 maldistribution by ML-7 or ML-9 significantly inhibited HPV pseudoviruses infection in vitro and in vivo. Meanwhile, N-glycans, especially the galactose chains, may act as the decoy receptors for HPV, which can block the interaction of HPV to myosin-9 and influence the way of HPV infection. Taken together, we identify myosin-9 as a novel functional entry receptor for high-risk HPV both in vitro and in vivo, and unravel the new roles of myosin-9 and N-glycans in HPV entry, which provides the possibilities for host targets of antiviral drugs. Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.

Citation

Yang Zhang, Wei Liu, Fujie He, Yan-Jun Liu, Hao Jiang, Cui Hao, Wei Wang. Myosin 9 and N-glycans jointly regulate human papillomavirus entry. The Journal of biological chemistry. 2024 Feb;300(2):105660

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 38242322

View Full Text